Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma (Q90744981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

review article

3 references

19 July 2022

23 July 2022

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

hepatocellular carcinoma

1 reference

Xiaolin Wu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Jiahui Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Asmae Gassa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Denise Buchner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Hakan Alakus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Qiongzhu Dong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Ning Ren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Ming Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Margarete Odenthal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Dirk Stippel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Christiane Bruns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Yue Zhao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Roger Wahba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

publication date

5 March 2020

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

19 July 2022

23 July 2022

International Journal of Biological Sciences

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

19 July 2022

23 July 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

page(s)

1551-1562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

16 April 2020

2 references

19 July 2022

23 July 2022

Free DNA in the serum of cancer patients and the effect of therapy.

1 reference

12 December 2020

RGS10 is a selective activator of G alpha i GTPase activity

1 reference

12 December 2020

The INK4 family of cell cycle inhibitors in cancer

1 reference

12 December 2020

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

12 December 2020

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

12 December 2020

Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis

1 reference

12 December 2020

Targeting RAS signalling pathways in cancer therapy

1 reference

12 December 2020

Polysialyltransferases: major players in polysialic acid synthesis on the neural cell adhesion molecule

1 reference

12 December 2020

Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway

1 reference

12 December 2020

beta-catenin destruction complex: insights and questions from a structural perspective

1 reference

12 December 2020

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

1 reference

12 December 2020

Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Next-generation DNA sequencing

1 reference

12 December 2020

1 reference

12 December 2020

Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells

1 reference

12 December 2020

Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing

1 reference

12 December 2020

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

1 reference

12 December 2020

Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission

1 reference

12 December 2020

The bile acid membrane receptor TGR5: a valuable metabolic target

1 reference

12 December 2020

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

1 reference

12 December 2020

Effect of the GPI anchor of human Thy-1 on antibody recognition and function

1 reference

12 December 2020

Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma

1 reference

12 December 2020

Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.

1 reference

12 December 2020

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

1 reference

12 December 2020

MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.

1 reference

12 December 2020

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma.

1 reference

12 December 2020

Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing

1 reference

12 December 2020

Targeted deep DNA methylation analysis of circulating cell-free DNA in plasma using massively parallel semiconductor sequencing

1 reference

12 December 2020

Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip

1 reference

12 December 2020

Circulating free DNA in the progression of liver damage to hepatocellular carcinoma.

1 reference

12 December 2020

Role of RUNX2 in Breast Carcinogenesis

1 reference

12 December 2020

Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients

1 reference

12 December 2020

Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)

1 reference

12 December 2020

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers

1 reference

12 December 2020

Wnt signaling in cancer.

1 reference

12 December 2020

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma

1 reference

12 December 2020

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma

1 reference

12 December 2020

The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.

1 reference

12 December 2020

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

1 reference

12 December 2020

A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.

1 reference

12 December 2020

Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.

1 reference

12 December 2020

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma

1 reference

12 December 2020

Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma

1 reference

12 December 2020

Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response

1 reference

12 December 2020

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

1 reference

12 December 2020

Direct detection of early-stage cancers using circulating tumor DNA.

1 reference

12 December 2020

5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.

1 reference

12 December 2020

Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers

1 reference

12 December 2020

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids

1 reference

12 December 2020

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers

1 reference

12 December 2020

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review

1 reference

12 December 2020

Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.

1 reference

12 December 2020

Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer

1 reference

12 December 2020

Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.

1 reference

12 December 2020

Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer

1 reference

12 December 2020

Detection and localization of surgically resectable cancers with a multi-analyte blood test.

1 reference

12 December 2020

Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.

1 reference

12 December 2020

AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.

1 reference

12 December 2020

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.

1 reference

12 December 2020

CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data.

1 reference

12 December 2020

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with -Mutated Hepatocellular Carcinoma

1 reference

12 December 2020

Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma

1 reference

12 December 2020

The roles of metallothioneins in carcinogenesis

1 reference

12 December 2020

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

1 reference

12 December 2020

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma

1 reference

12 December 2020

Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence

1 reference

12 December 2020

Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management

1 reference

12 December 2020

Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma

1 reference

12 December 2020

Application of Cell-free DNA Analysis to Cancer Treatment

1 reference

12 December 2020

Current and future perspectives of liquid biopsies in genomics-driven oncology

1 reference

12 December 2020

Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence

1 reference

12 December 2020

Cell-Free DNA: An Overview of Sample Types and Isolation Procedures

1 reference

12 December 2020

Artificial intelligence in cancer imaging: Clinical challenges and applications

1 reference

12 December 2020

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

1 reference

12 December 2020

Hepatocellular Carcinoma

1 reference

12 December 2020

Application of plasma circulating cell-free DNA detection to the molecular diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer

1 reference

12 December 2020

Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma

1 reference

12 December 2020

Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma

1 reference

12 December 2020

Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma

1 reference

12 December 2020

Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma

1 reference

12 December 2020

Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA

1 reference

12 December 2020

Identifiers

DOI

10.7150/IJBS.44024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

PubMed publication ID

32226301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32226301%20AND%20SRC:MED&resulttype=core&format=json